Citadel Advisors’s Silence Therapeutics SLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-62,441
| Closed | -$176K | – | 6879 |
|
|
2025
Q1 | $176K | Sell |
62,441
-220,296
| -78% | -$621K | ﹤0.01% | 4925 |
|
|
2024
Q4 | $1.95M | Sell |
282,737
-153,960
| -35% | -$1.06M | ﹤0.01% | 2635 |
|
|
2024
Q3 | $7.94M | Buy |
436,697
+319,937
| +274% | +$5.82M | ﹤0.01% | 1424 |
|
|
2024
Q2 | $2.22M | Buy |
116,760
+74,078
| +174% | +$1.41M | ﹤0.01% | 2344 |
|
|
2024
Q1 | $922K | Buy |
42,682
+20,945
| +96% | +$452K | ﹤0.01% | 3279 |
|
|
2023
Q4 | $378K | Buy |
+21,737
| New | +$378K | ﹤0.01% | 4020 |
|
|
2022
Q4 | – | Sell |
-22,851
| Closed | -$226K | – | 6651 |
|
|
2022
Q3 | $226K | Buy |
22,851
+11,410
| +100% | +$113K | ﹤0.01% | 4766 |
|
|
2022
Q2 | $136K | Buy |
+11,441
| New | +$136K | ﹤0.01% | 5154 |
|